Enzyme Linked Immunosorbent Assay Market Is Estimated To Witness High Growth Owing To Increasing Demand for Diagnostic Tests
The global Enzyme Linked Immunosorbent Assay (ELISA) market is estimated to be valued at US$ 2,016.1 million in 2022 and is expected to exhibit a CAGR of 5.1% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. A) Market Overview: ELISA is a widely used laboratory technique used for detecting and quantifying proteins, antibodies, and hormones. It is used in various applications such as diagnostics, research, and quality control testing in pharmaceutical and biotechnology industries. The primary advantage of ELISA is its high sensitivity, specificity, and ability to process multiple samples simultaneously. The increasing demand for diagnostic tests owing to the rising prevalence of chronic diseases is driving the growth of the ELISA market. B) Market Key Trends: One key trend in the ELISA market is the growing adoption of ELISA in infectious disease testing. ELISA is extensively used for the detection of viral infections such as HI...